Fresenius Kabi announced today that it launched two new presentations of Heparin sodium in its Freeflex IV bags.
Lake Zurich, Ill.–based Fresenius Kabi’s Heparin sodium in sodium chloride injection at a concentration of two USP units per ml is indicated as an anticoagulant to maintain catheter patency, according to a news release.
Available in two strengths (1,000 USP units in 0.9% sodium chloride 500 mL infusion bag/2,000 USP unites in 0.9% sodium chloride 1,000 ml infusion bag), the heparin sodium is delivered with Fresenius Kabi’s convenient, ready-to-administer Freeflex IV bags.
Freeflex is a multilayer, polyolefin film container designed to reduce end users’ steps compared to using vials with leak-resistant technology and an easy-to-handle design for infusion therapies.
In addition to the Freeflex premixed bags, Heparin sodium therapies are also offered in Fresenius Kabi’s Simplist prefilled syringes and vials.
“In line with our commitment to offering convenient, ready-to-administer products to help minimize drug errors and assure patient safety, we are pleased to introduce a low concentration option in our line of Heparin Sodium in Sodium Chloride,” Fresenius Kabi USA president & CEO John Ducker said in the release. “We remain focused on meeting clinicians’ needs by expanding the variety of presentations of products we offer in Freeflex IV bags and Simplist prefilled syringes.”